• All Courts
  • Federal Courts
  • Bankruptcies
  • PTAB
  • ITC
Track Search
Export
Download All
Active Filters
Displaying 129-143 of 224 results

2061 Exhibit: Swanson, Canadian Child Adolesc Psych Re 1 4 3 2005

Document IPR2018-00293, No. 2061-108 Exhibit - Swanson, Canadian Child Adolesc Psych Re 1 4 3 2005 (P.T.A.B. Oct. 23, 2018)

cite Cite Document
Analyze

1020 Exhibit: 1020 FDA Review 2002 Adderall

Document IPR2018-00293, No. 1020-21 Exhibit - 1020 FDA Review 2002 Adderall (P.T.A.B. Dec. 11, 2017)

cite Cite Document
Analyze

2019 Exhibit: Patrick, Human Psychopharmacology, 12 527 546 1997

Document IPR2018-00293, No. 2019-64 Exhibit - Patrick, Human Psychopharmacology, 12 527 546 1997 (P.T.A.B. Apr. 10, 2018)

cite Cite Document
Analyze

1003 Exhibit: 1003 PDR 2004 Adderall

Document IPR2018-00293, No. 1003-3 Exhibit - 1003 PDR 2004 Adderall (P.T.A.B. Dec. 11, 2017)

cite Cite Document
Analyze

1018 Exhibit: 1018 US Patent No 6,555,136

Document IPR2018-00293, No. 1018-19 Exhibit - 1018 US Patent No 6,555,136 (P.T.A.B. Dec. 11, 2017)

cite Cite Document
Analyze

2002 Exhibit: DECLARATION OF SARA ROSENBAUM, PhD with CV

Document IPR2018-00293, No. 2002-45 Exhibit - DECLARATION OF SARA ROSENBAUM, PhD with CV (P.T.A.B. Apr. 10, 2018)

cite Cite Document
Analyze

1061 Exhibit: Petitioners Demonstrative Exhibits

Document IPR2018-00293, No. 1061-151 Exhibit - Petitioners Demonstrative Exhibits (P.T.A.B. Apr. 2, 2019)

cite Cite Document
Analyze

1058 Exhibit: KVK TECH Exhibit 1058 Corrected Declaration of James McCracken,...

Document IPR2018-00293, No. 1058-150 Exhibit - KVK TECH Exhibit 1058 Corrected Declaration of James McCracken, MD (P.T.A.B. Mar. 15, 2019)

cite Cite Document
Analyze

2030 Exhibit: Rowland, Clinical Pharmacokinetics 2d 1989

Document IPR2018-00293, No. 2030-75 Exhibit - Rowland, Clinical Pharmacokinetics 2d 1989 (P.T.A.B. Apr. 10, 2018)

cite Cite Document
Analyze

2006 Exhibit: Amidon, US Patent No 5,229,131

Document IPR2018-00293, No. 2006-49 Exhibit - Amidon, US Patent No 5,229,131 (P.T.A.B. Apr. 10, 2018)

cite Cite Document
Analyze

1037 Exhibit: 1037 McCracken

Document IPR2018-00293, No. 1037-38 Exhibit - 1037 McCracken (P.T.A.B. Dec. 11, 2017)

cite Cite Document
Analyze

1014 Exhibit: 1014 Tulloch Adderall XR

Document IPR2018-00293, No. 1014-15 Exhibit - 1014 Tulloch Adderall XR (P.T.A.B. Dec. 11, 2017)

cite Cite Document
Analyze

2046 Exhibit: Spencer, Current Diagn Treatment Psych, Ch 35 ADHD 2008

Document IPR2018-00293, No. 2046-91 Exhibit - Spencer, Current Diagn Treatment Psych, Ch 35 ADHD 2008 (P.T.A.B. Apr. 10, 2018)

cite Cite Document
Analyze

2048 Exhibit: Gibaldi, Biopharmaceutics Clinical Pharmacokinetics, Ch 7 1991

Document IPR2018-00293, No. 2048-93 Exhibit - Gibaldi, Biopharmaceutics Clinical Pharmacokinetics, Ch 7 1991 (P.T.A.B. Apr. 10, 2018)

cite Cite Document
Analyze

1026 Exhibit: 1026 Wagner

Document IPR2018-00293, No. 1026-27 Exhibit - 1026 Wagner (P.T.A.B. Dec. 11, 2017)

cite Cite Document
Analyze
<< 1 2 3 4 5 ... 9 10 11 12 13 14 15 16 >>